Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02000583 · ClinicalTrials.gov registry record · NA

Alzheimer's Prevention Through Exercise

A NA study, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT02000583 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 117 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02000583, a NA study, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

The purpose of this study is to learn about the possible benefits of aerobic exercise in controlling or reducing the amount of amyloid present in the brain, reducing changes in brain structure that may lead to Alzheimer's Disease (AD), and increasing cognitive ability in individuals that have amyloid deposits and are at risk to develop AD.

Interventions

  • OTHER Standard of Care
  • OTHER Aerobic Exercise

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2013-11
Est. Completion 2019-12-31
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT02000583

The ClinicalTrials.gov registry entry for NCT02000583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT02000583 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02000583 about?

NCT02000583 is a clinical study titled "Alzheimer's Prevention Through Exercise". The purpose of this study is to learn about the possible benefits of aerobic exercise in controlling or reducing the amount of amyloid present in the brain, reducing changes in brain structure that may lead to Alzheimer's Disease (AD), and increasing cognitive ability in individuals that have amyloi...

What is the current status of trial NCT02000583?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2013-11. Estimated completion is 2019-12-31.

What interventions are being tested in trial NCT02000583?

The interventions under investigation include: Standard of Care (OTHER), Aerobic Exercise (OTHER).

Who is sponsoring clinical trial NCT02000583?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.